{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:39:17Z","timestamp":1792618757864,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.acvd.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:13:06Z","timestamp":1791558786000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and predictors of urinary tract infections after sodium-glucose cotransporter 2 inhibitor initiation in older adults hospitalized for heart failure"],"prefix":"10.1016","author":[{"given":"Jean-Baptiste","family":"Robiaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Leroy-Mobeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Berrut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Dalberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Gentreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Marroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Blain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2026.09.004_bib0180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2026.09.004_bib0185","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2026.09.004_bib0190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.amjmed.2022.08.009","article-title":"Activities of daily living and outcomes in patients with advanced heart failure","volume":"135","author":"Roy","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2026.09.004_bib0195","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.acvd.2026.09.004_bib0200","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.acvd.2024.10.004","article-title":"Epidemiology of heart failure in France","volume":"117","author":"Gabet","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2026.09.004_bib0205","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2026.09.004_bib0210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.acvd.2026.09.004_bib0215","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.acvd.2026.09.004_bib0220","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.acvd.2026.09.004_bib0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.acvd.2026.09.004_bib0230","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2026.09.004_bib0235","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2026.09.004_bib0240","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2026.09.004_bib0245","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.acvd.2026.09.004_bib0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.acvd.2024.09.004","article-title":"2023 SFMU\/GICC-SFC\/SFGG expert recommendations for the emergency management of older patients with acute heart failure. Part 2: therapeutics, pathway of care and ethics","volume":"118","author":"Peschanski","year":"2025","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2026.09.004_bib0255","doi-asserted-by":"crossref","first-page":"l525","DOI":"10.1136\/bmj.l525","article-title":"Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study","volume":"364","author":"Gharbi","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2026.09.004_bib0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ydbio.2022.11.003","article-title":"Effects of aging on urinary tract epithelial homeostasis and immunity","volume":"493","author":"Ligon","year":"2023","journal-title":"Dev Biol"},{"issue":"2","key":"10.1016\/j.acvd.2026.09.004_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/501875","article-title":"Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference","volume":"22","author":"Loeb","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.acvd.2026.09.004_bib0270","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/667743","article-title":"Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria","volume":"33","author":"Stone","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.acvd.2026.09.004_bib0275","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.acvd.2026.09.004_bib0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12874-016-0267-3","article-title":"No rationale for 1 variable per 10 events criterion for binary logistic regression analysis","volume":"16","author":"van Smeden","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.acvd.2026.09.004_bib0285","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2024.01.040","article-title":"Genitourinary tract infections in patients taking SGLT2 inhibitors: JACC review topic of the week","volume":"83","author":"Kittipibul","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2026.09.004_bib0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology Guidelines on urological infections: Summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.acvd.2026.09.004_bib0295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JU.0000000000004723","article-title":"Updates to recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline (2025)","volume":"215","author":"Ackerman","year":"2026","journal-title":"J Urol"},{"key":"10.1016\/j.acvd.2026.09.004_bib0300","doi-asserted-by":"crossref","first-page":"e43245","DOI":"10.1097\/MD.0000000000043245","article-title":"Risk factors of urinary tract infections with sodium-glucose cotransporter-2 inhibitors in heart failure","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.acvd.2026.09.004_bib0305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10741-023-10363-w","article-title":"Adverse effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis","volume":"29","author":"Pozzi","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.acvd.2026.09.004_bib0310","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cardfail.2024.04.009","article-title":"Sodium-glucose cotransporter 2 inhibitors and mycotic genital or urinary tract infections in heart failure","volume":"30","author":"Duvalyan","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.acvd.2026.09.004_bib0315","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1111\/dom.15193","article-title":"Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"25","author":"Rigato","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.acvd.2026.09.004_bib0320","series-title":"The use of the WHO-UMC system for standardised case causality assessment","year":"2018"},{"key":"10.1016\/j.acvd.2026.09.004_bib0325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.acvd.2026.09.004_bib0330","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40266-025-01230-4","article-title":"Optimizing prevention of recurrent urinary tract infections in older patients with frailty","volume":"42","author":"Hjelholt","year":"2025","journal-title":"Drugs Aging"},{"issue":"6\u20137","key":"10.1016\/j.acvd.2026.09.004_bib0335","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.acvd.2025.11.010","article-title":"Real-world persistence with sacubitril\/valsartan in patients with heart failure in France: a claims database study","volume":"119","author":"Hanon","year":"2026","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2026.09.004_bib0340","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1111\/dom.70003","article-title":"Association between sodium-glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection","volume":"27","author":"Wang","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.acvd.2026.09.004_bib0345","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1111\/jgs.70143","article-title":"SGLT2 inhibitors in older adults with cardiovascular disease: a systematic review and meta-analysis","volume":"73","author":"Minami","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.acvd.2026.09.004_bib0350","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/M21-4284","article-title":"Sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis","volume":"175","author":"Zou","year":"2022","journal-title":"Ann Intern Med"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626003517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626003517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:00:59Z","timestamp":1792616459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213626003517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S1875213626003517"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2026.09.004","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and predictors of urinary tract infections after sodium-glucose cotransporter 2 inhibitor initiation in older adults hospitalized for heart failure","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}